Top 10 Companies influencing in Microfluidics Industry

Microfluidics involves various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. It is an emerging technology having a wide range of applications in biology, chemistry, optics, and information technology. This technology is widely used in techniques such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, and PCR amplification. Additionally, microfluidics is also used in disease research and diagnosis. The rising demand for microfluidics technologies in point-of-care testing and innovation in microfluidics products are the major factors contributing to the growth of the global microfluidics market. However, the market growth is restrained by the lower adoption of these products in emerging economies.

Top 10 Companies Working in this Study:

1. Agilent Technologies, Inc.
2. BD
3. Bio-Rad Laboratories Inc.,
4. Danaher
5. Dolomite Microfluidics (Blacktrace Holdings Ltd.)
6. Fludigm Corporation
7. Illumina, Inc.
8. microfluidic ChipShop GmbH
9. Perkin Elmer, Inc.
10. Thermo Fisher Scientific Inc.

Microfluidics is fast becoming a key technology in a wide range of fields, including medical sciences, biosensing, bioactivation, chemical synthesis, and more. This is contributing to its transformation from a promising R&D tool to a commercially viable technology. Fueling this expansion is the intensified focus on automation and enhanced functionality through the integration of complex electrical control, mechanical properties, on-site sensing and flow control.

Microfluidics allows biotechnological processes to develop on a scale (microns) in which physical processes such as osmotic movement, electrophoretic motility, and surface interactions are enhanced. At the microscale, sample volumes and analysis times are reduced, and procedural costs are reduced. The versatility of microfluidic devices allows interaction with current methods and technologies. Microfluidics has been applied to DNA analysis methods and has been shown to speed up the hybridization times of the DNA microarray assay. Linking microfluidics to protein analysis technologies, p. Eg Mass spectrometry allows to analyze picomole amounts of peptide in a controlled microenvironment. The flexibility of microfluidics will facilitate their exploitation in assay development in multiple biotechnology disciplines.

A few major product launches are mentioned below:

In February 2020, Miroculus, Inc., unveiled its Miro Canvas at the Advances in Genome Biology and Technology conference. The Miro Canvas system will automate and miniaturize complex protocols such as NGS library prep and improving library consistency. Also, it will decrease sample input requirements and reagent volumes.

In January 2020, Nicoya launched the Alto surface plasmon resonance (SPR) system. It is a first fully-automated, high-throughput system that integrates digital microfluidics (DMF), artificial intelligence (AI), and nanotechnology. It offers high quality, label-free interaction analysis. This product is designed to reduce the time and cost of drug discovery.

In November 2019, MicroMedicine, Inc., launched Sorterra Cell Isolation System. This new, patented automated technology isolates white blood cells from human peripheral blood using microfluidic channels without the use of centrifugation or labeling.

Click Here to Get Sample PDF Copy

Life scientists are working closely with engineers to solve biological and biomedical problems through the application of engineering tools. For the engineers involved in this collaborative work, new knowledge is created in their own disciplines. For example, science and technology at the interface of biomedical, Hence, microfluidic sciences has played an important role in initiating recent advances in genomics, proteomics, single cell analysis, and laboratory-on-chip (LOC) / point of care. (POC diagnosis). The increasing technological advancements in diagnostic devices and the rising incidence of chronic diseases are encouraging the adoption of microfluidics in disease diagnosis.